HIF-1α also directly regulates BCL-xL, which is a hypoxia-responsive, anti-apoptotic protein of the Bcl-2 family and is also overexpressed in prostate carcinoma and many other cancers (16). Here, HIF1A is linked to prostate carcinoma.